Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China.
Department of Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Eur Radiol. 2022 Aug;32(8):5623-5632. doi: 10.1007/s00330-022-08656-z. Epub 2022 Mar 16.
Posthepatectomy liver failure (PHLF) is a challenging complication after resection to treat hepatocellular carcinoma (HCC), and it is associated with high mortality. Preoperative prediction of PHLF may improve patient subsequent and reduce such mortality. This study examined whether a functional liver imaging score (FLIS) based on preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI) could predict PHLF.
The study included 502 patients who underwent preoperative gadoxetic acid-enhanced MRI, followed by HCC resection. Significant preoperative predictors of PHLF were identified using logistic regression analysis. The ability of FLIS to predict PHLF was evaluated using receiver operating characteristic curves, and its predictive power was compared to that of the model for end-stage liver disease (MELD) score, albumin-bilirubin (ALBI) score, and indocyanine green 15-min retention rate (ICG-R15).
In multivariate analysis, PHLF was independently associated with FLIS (OR 0.452, 95% CI 0.361 to 0.568, p < 0.001) and major resection (OR 1.898, 95% CI 1.057 to 3.408, p = 0.032). FLIS was associated with a higher area under the receiver operating characteristic curve (0.752) than the MELD score (0.557), ALBI score (0.609), or ICG-R15 (0.605) (all p < 0.05). Patients with FLIS ≤ 4 who underwent major resection were at 9.4-fold higher risk of PHLF than patients with lower FLIS who underwent minor resection.
FLIS is an independent predictor of PHLF, and it may perform better than the MELD score, ALBI score, and ICG-R15 clearance. We propose treating elevated FLIS and major resection as risk factors for PHLF.
• A functional liver imaging score can independently predict posthepatectomy liver failure in patients with HCC. • The score may predict such failure better than MELD and ALBI scores and ICG-R15. • Patients with scores ≤ 4 who undergo major hepatic resection may be at nearly tenfold higher risk of posthepatectomy liver failure.
肝切除术后肝功能衰竭(PHLF)是治疗肝细胞癌(HCC)后发生的一种具有挑战性的并发症,与高死亡率相关。术前对 PHLF 的预测可能会改善患者的预后并降低死亡率。本研究旨在探讨基于术前钆塞酸增强磁共振成像(MRI)的功能性肝脏成像评分(FLIS)是否可预测 PHLF。
本研究纳入了 502 例接受术前钆塞酸增强 MRI 检查并随后行 HCC 切除术的患者。采用 logistic 回归分析确定 PHLF 的显著术前预测因素。采用受试者工作特征曲线评估 FLIS 预测 PHLF 的能力,并将其预测能力与终末期肝病模型(MELD)评分、白蛋白-胆红素(ALBI)评分和吲哚菁绿 15 分钟滞留率(ICG-R15)进行比较。
多因素分析显示,PHLF 与 FLIS(OR 0.452,95%CI 0.361 至 0.568,p < 0.001)和大切除术(OR 1.898,95%CI 1.057 至 3.408,p = 0.032)独立相关。FLIS 与更高的受试者工作特征曲线下面积(0.752)相关,优于 MELD 评分(0.557)、ALBI 评分(0.609)或 ICG-R15(0.605)(均 p < 0.05)。FLIS ≤ 4 且接受大切除术的患者发生 PHLF 的风险是接受小切除术且 FLIS 较低的患者的 9.4 倍。
FLIS 是 PHLF 的独立预测因子,其性能可能优于 MELD 评分、ALBI 评分和 ICG-R15 清除率。我们建议将升高的 FLIS 和大切除术视为 PHLF 的危险因素。
功能性肝脏成像评分可独立预测 HCC 患者的肝切除术后肝功能衰竭。
该评分预测肝切除术后肝功能衰竭的能力可能优于 MELD 和 ALBI 评分以及 ICG-R15。
评分 ≤ 4 且接受大肝切除术的患者发生肝切除术后肝功能衰竭的风险几乎增加 10 倍。